Fingerprint
Dive into the research topics of 'Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatment'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically